Impact of Shunt-Related Hemorrhage on Seizure Development After Ventricular Shunt Surgery in Idiopathic Normal Pressure Hydrocephalus.
Munetake Yoshitomi, Takahisa Nonaka, Ryusei Nobori, Keiichiro Furuta, Naohisa Miyagi, Yuji Okamoto, Kazunori Kajihara, Kenta Murotani, Motohiro Morioka
Abstract
Open AccessBACKGROUND AND OBJECTIVE: Ventricular shunt surgery, with either ventriculoperitoneal (VP) or ventriculoatrial (VA) shunts, is a primary treatment of idiopathic normal pressure hydrocephalus. However, postoperative seizures can complicate recovery. In this study, we investigated risk factors of postoperative seizures and assessed the risk of shunt-related hemorrhage. METHODS: Patients who underwent VP or VA shunt surgery for idiopathic normal pressure hydrocephalus between April 2020 and March 2023 were retrospectively reviewed. Exclusion criteria included a history of epilepsy or shunt revision surgery. Collected data included patient demographics, incidence of shunt-related intracranial hemorrhage, antithrombotic use, preoperative international normalized ratio, platelet count (within 2 weeks preoperatively), postoperative CRP levels (on day 1), time to seizure onset, and previous intracranial hemorrhage, cerebral infarction, or neurosurgery. Follow-up duration was recorded. RESULTS: This study enrolled 185 patients (102 men) with a mean age of 79.2 years (range: 53-94). Of these, 153 and 32 patients underwent VP and VA shunt surgery, respectively. Intracranial hemorrhage history was present in 9 patients (4.8%), cerebral infarction in 43 (23.2%), and previous intracranial surgery in 9 (4.8%). Hypertension was noted in 91 patients (49.1%). The mean CRP level on postoperative day 1 was 2.01 mg/dL (range: 0.05-14.99), whereas the mean preoperative international normalized ratio was 1.03 (range: 0.11-1.68). Shunt-related intracranial hemorrhage occurred in 14 patients (7.5%) and seizures in 8 (4%). Antithrombotic agents were used in 32 patients (17.2%). Patients with seizures had a higher incidence of shunt-related hemorrhage. Older age, previous intracranial surgery, and antithrombotic use were significantly associated with shunt-related hemorrhage. Logistic analysis identified shunt-related hemorrhage as a risk factor of seizures up to 2 years postoperatively. CONCLUSION: Our findings underscore the significance of shunt-related intracranial hemorrhage as a contributing factor to seizures after ventricular shunt surgery. This risk should be clearly communicated to patients during the informed consent process.